Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,081,000 | 3,197,000 | 2,456,000 | 5,687,000 | 7,513,000 |
| Depreciation Amortization | 1,508,000 | 1,005,000 | 503,000 | 1,765,000 | 1,323,000 |
| Income taxes - deferred | -77,000 | 72,000 | N/A | -1,517,000 | N/A |
| Accounts receivable | -207,000 | -96,000 | -316,000 | -591,000 | -806,000 |
| Accounts payable and accrued liabilities | 494,000 | -366,000 | 94,000 | 734,000 | 881,000 |
| Other Working Capital | -838,000 | -1,850,000 | -495,000 | 467,000 | -295,000 |
| Other Operating Activity | 4,088,000 | 3,532,000 | 775,000 | 6,882,000 | 1,419,000 |
| Operating Cash Flow | $10,049,000 | $5,494,000 | $3,017,000 | $13,427,000 | $10,035,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -389,000 | -235,000 | -107,000 | -638,000 | -515,000 |
| Net Acquisitions | -476,000 | -440,000 | -320,000 | -736,000 | -541,000 |
| Purchase Of Investment | -579,000 | -558,000 | -194,000 | -1,792,000 | -1,581,000 |
| Sale Of Investment | 2,655,000 | 1,066,000 | 594,000 | 2,160,000 | 1,914,000 |
| Investing Cash Flow | $1,211,000 | $-167,000 | $-27,000 | $-1,006,000 | $-723,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -699,000 | -393,000 | -200,000 | 3,301,000 | 2,602,000 |
| Debt Issued | 1,534,000 | 0 | N/A | 5,963,000 | 5,963,000 |
| Debt Repayment | -5,000 | -4,000 | N/A | -6,035,000 | -5,021,000 |
| Common Stock Issued | 6,000 | 5,000 | 4,000 | 73,000 | 66,000 |
| Common Stock Repurchased | -627,000 | -623,000 | -620,000 | -12,014,000 | -9,956,000 |
| Dividend Paid | -4,771,000 | -3,180,000 | -1,588,000 | -5,580,000 | -4,129,000 |
| Other Financing Activity | -3,332,000 | -3,258,000 | -2,979,000 | -104,000 | -96,000 |
| Financing Cash Flow | $-7,894,000 | $-7,453,000 | $-5,383,000 | $-14,396,000 | $-10,571,000 |
| Exchange Rate Effect | -7,000 | 9,000 | 1,000 | -39,000 | -29,000 |
| Beginning Cash Position | 7,289,000 | 7,289,000 | 7,289,000 | 9,303,000 | 9,303,000 |
| End Cash Position | 10,648,000 | 5,172,000 | 4,897,000 | 7,289,000 | 8,015,000 |
| Net Cash Flow | $3,359,000 | $-2,117,000 | $-2,392,000 | $-2,014,000 | $-1,288,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,049,000 | 5,494,000 | 3,017,000 | 13,427,000 | 10,035,000 |
| Capital Expenditure | -389,000 | -235,000 | -107,000 | -638,000 | -515,000 |
| Free Cash Flow | 9,660,000 | 5,259,000 | 2,910,000 | 12,789,000 | 9,520,000 |